Introduction
Positron emission tomography (PET) is a powerful noninvasive modality for the visualization of biological functions, in real time, using a positron emitting nuclide incorporated into a bioactive molecule (tracer). 1, 2 PET is an important clinical diagnostic tool and has found extensive use in the monitoring of disease progression and treatment response in cancer patients. [2] [3] [4] PET has also emerged as an enabling tool to study the underlying biological processes in many neurological disorders and in the development of drugs targeting the CNS. 5 One of the most important nuclides used in PET is the cyclotron-produced carbon-11 ( 11 C) with a half-life of 20.4 min. 6 This is mainly due to the potential introduction of the carbon nuclide into various positions in a molecule of interest without disturbing its biological activity. 11 C is typically produced in the form of 11 C-carbon dioxide ( 11 CO2) and can be readily transformed into a number of key building blocks including 11 C-carbon monoxide ( 11 CO). 7, 8 The synthetic versatility of 11 CO is well-known and it can be utilized in various metal-mediated reactions yielding a host of different carbonyl and carboxylic acid derivatives including amides, acids, esters and ketones. [9] [10] [11] [12] [13] Despite these advances, there are a multitude of biologically important functional groups and scaffolds that cannot be prepared using existing 11 CO technology. This highlights one of the major limitations of PET, namely the lack of generally applicable methods for the incorporation of the radionuclide into a target molecule. This has created a situation where tracer synthesis is dominated by a handful of synthetic methods (e.g. methylation) and potential tracers are invariably designed to conform within the narrow confines of existing chemistry, rather being naturally guided by target biology. To overcome these issues, there is an increasing demand for the development of new radiochemical methods that are suitable for the labelling of complex biologically active molecules. The use of 11 C, however, poses a number of additional challenges as the short half-life of 11 C demands the development of fast and efficient reactions.
Bioisosteric replacement has played a vital role in drug discovery and development since the term was first coined in H F 14, 15 The concept is based upon the assumption that atoms or functional groups with comparably shapes and/or physicochemical properties will interact similarly with a biological target and elicit analogous biological effects. 15 Thus, bioisosteres have been employed to improve potency and selectivity, alter physical properties, modulate metabolism, increase permeability and adsorption and reduce the toxicity of a biologically active compound. 16 However, despite the widespread use of bioisosteres to optimize these properties in drug discovery and development, this strategy remains largely unexplored in the field of PET tracer development.
The carboxylic acid is an important functional group capable of interacting with a biological target through both hydrogen bonding and electrostatic interactions. Carboxylic acids can also increase aqueous solubility and influence pharmacokinetics and are found in a wide range of drug and biologically active molecules. This has led to the development of several bioisosteres for this moiety. [15] [16] [17] [18] [19] [20] N-Cyanobenzamides (Scheme 1) are an interesting, yet relatively unexplored, class of carbonyl derivatives. 21, 22 They have been employed as intermediates in the synthesis of diverse heterocyclic scaffolds and they have also found utility as carboxylic acid bioisosteres in a number of biologically active molecules. 20, 23, 24 Recently, we reported the carbonylative synthesis of this functional group, under palladium(0)catalysis, starting from an aryl halide, cyanamide and carbon monoxide using a bridged two compartment setup. 25, 26 Realizing that this provided an excellent starting point for the development of 11 CO-carbonylation chemistry we sought to develop the first synthetic procedure for the preparation of 11 C-labelled N-cyanobenzamides. 6, 27 This would make a valuable addition to the radiochemistry toolbox, opening up a new area of 11 C-chemical space, that can be exploited in the design and synthesis of novel PET tracers. Herein, we describe a rapid, robust and high yielding method for the preparation of 11 C-N-cyanobenzamides via a palladium mediated carbonylation using an aryl halide, cyanamide and 11 CO (Scheme 1). Scheme 1. Pd-mediated synthesis of 11 C-N-cyanobenzamides and 11 C-benzamides
Results and discussion

Method development
We initiated our search for suitable reaction conditions using iodobenzene and cyanamide as model substrates, with bis(dibenzylidene-acetone)palladium(0) as the palladium source. THF has previously been successfully used as a solvent for 11 C-carbonylations, 28 however, the more polar DMF readily dissolved all components and was therefore chosen for further evaluation. The radiotrapping efficiency (RTE, defined here as the fraction of immobilized 11 CO at the end of synthesis [EOS]) was determined by removal of non-reacted 11 CO by flushing the crude reaction mixture with helium for 1 min.
The ligand-free carbonylation resulted in a RTE of 85% and gave conversion of trapped 11 CO to product (RCP) of 88% ( Table 1 , entry 1) as measured by radio-HPLC. We continued by evaluating the monodentate ligand triphenyphosphine, which gave the desired product in the same quantity (RTE 95%, RCP 75%, entry 2). Analysis of the crude reaction mixture suggested the presence of a side-product, which was identified as 11 Cbenzoic acid by co-elution using analytical radio-HPLC. The bidentate ligand 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos) has previously been successfully in both 11 CO and CO carbonylations. 9, [29] [30] [31] In our setup complete consumption of 11 CO (RTE >99%) was achieved with this ligand at 120 °C and 150 °C but with lower RCP (61% and 72%, entry 3-4). Interestingly, no formation of acid was detected using this ligand. The lower RCP was due to the formation of a highly lipophilic impurity, possibly the 11 CO-PdXantphos intermediate prior to nucleophilic attack by cyanamide. 29 We continued our ligand screening by using the less strained oxydi-2,1-phenylene)bis(diphenylphosphine) (DPEphos), however full trapping of 11 CO was not achieved in the range 90-150 °C and no improvement in RCP was observed (entry 5-T -bis(diphenylphosphino)ferrocene (dppf) gave complete trapping of 11 CO (RTE >99%) and the desired product in high RCP (94±2%, entry 8). This may be attributed to the flexible ligand backbone, allowing it to stabilize the electronically and structurally disparate intermediates (i.e. Pd(0) and Pd(II)) formed during the reaction. [32] [33] [34] When the temperature was increased to 150 °C, small amounts of unknown side-products were detected in the reaction mixture (entry 9). Using lower temperature gave lower RTE (84%) indicating that higher temperatures were essential for the effective conversion of iodobenzene to the corresponding 11 C-N-cyanobenzamide 11 C2a. Please do not adjust margins
Please do not adjust margins 13) . Next, we proceeded by evaluating the less reactive chlorobenzene in the carbonylative reaction. At 170 °C the RTE was 63% and the RCP 74% (entry 14). The pseudo-halide phenyl triflate was reacted under similar conditions as iodobenzene and was found to smoothly undergo carbonylation at 120 °C with RTE of 89% and RCP of 88% (entry 15). With a suitable carbonylative protocol in hand, we continued by exploring the generality of the method using aryl iodides with different electronic properties ( Table 2) . Here the RTE and RCP for each reaction was determined as well as the isolated radiochemical yield (RCY) following semi-preparative HPLC. From iodobenzene and phenyl triflate 11 C-N-cyanobenzamide 11 C-2a was isolated in 79% and 72% RCY, respectively. Substrates bearing electron withdrawing (EWG) and electron donating (EDG) groups in the 4-position performed well affording the desired products in moderate to high isolated radiochemical yield ( 11 C-2b-f, 41-73%). A good yield was also obtained when the methoxy group was moved to the 3-position furnishing 64% RCY of 11 C-2g. Notably, full chemoselectivity was achieved in the reaction with 1-chloro-4-iodidobenzene and 57% of the 4-chloro substituted product 11 C-2e was obtained. Finally, the ortho-CF3 containing substrate (entry 9) gave a lower RCY (28%) of the corresponding 11 C-N-cyanobenzamide 11 C-2h presumably due to a combination of unfavorable steric and electronic effects. To further extend the utility of the reaction, the scope was expanded to include aryl-and heteroaromatic bromides (Table  3) . By using the protocol from entry 12 in Table 1 (i.e. increasing the temperature to 140 °C), 11 C-N-cyanobenzamide 11 C-2a was synthesized in 72% RCY. Using chlorobenzene at 170 °C furnished the same product in reduced 34% RCY (entry 2). Both the electron rich (entry 3) and electron deficient substrates (entry 4) gave corresponding products 11 C-2b and 11 C-2c in similar RCY wheras 2-bromonaphthalene 3e yielded labelled 11 C-4a in 51% RCY. A number of electron-rich heterocycles were also effectively transformed into the corresponding 11 C-Ncyanamide products. 2-Bromobenzofurane afforded 11 C-Ncyanobenzofuran-2-carboxamide ( 11 C-4b) in 48% RCY while 2-and 3-bromothiophene gave products 11 C-4c and 11 C-4d in 59% and 64% isolated RCY, respectively. Notably, 3-bromopyridine was transformed into 11 C-N-cyanonicotinamide ( 11 C-4e) in 55% RCY.
Synthesis of 11 C-cyanobenzamide analogs of various bioactive molecules
To further exemplify our developed methodology, we explored the labeling with 11 CO of N-cyanobenzamide analogs of a variety of bioactive molecules (Scheme 2). Firstly, we prepared the N-cyanobenzamide derivatives of flufenamic acid ( 11 C-6) and mefenamic acid ( 11 C-7), two nonsteroidal antiinflammatory and antipyretic drugs (NSAID) used to treat muscle and menstrual pain, respectively. [35] [36] [37] This required access to the ortho-bromoaniline precursors 5a and 5b, which were synthesized via a palladium-catalyzed amination using 5% tris(dibenzylidene-acetone)dipalladium(0) and 12% Xantphos as the ligand in 46% and 72% yield, respectively (Scheme 2A). 38 Despite the potentially palladium-coordinating amino moiety in close vicinity to the bromide, the reactions performed well at 140 °C yielding 11 C-6 in 54±2% RCY and 11 C-7 in 34±4% RCY. The precursor of the thromboxane synthase inhibitor dazoxiben was synthesized from 1-bromo-4-(2-chloroeth-oxy)benzene (8) and imidazole in 78% yield (Scheme 2B). Using the optimized conditions for aryl bromides, the radiolabelled 11 C-10 was isolated using semi-preparative HPLC in 71±4%.
Finally, we synthesized compound 11 a precursor for the labelling of tamibarotene, a synthetic retinoic acid receptor agonist. 39, 40 Tamibarotene is approved in Japan for use against all-trans-retinoic acid refractive acute promyelocytic leukemia 41 and is currently being investigated for the treatment of insulin resistence, 42 vasculitis 43 intracerebral hemorrhage 44 A 45,46 11 C-Tamibarotene ( 11 C-13) was prepared from the iodo-precursor 11 via an alkoxycarbonylation using the conditions from Table 3 at 150 °C using methanol as the nucleophile (Scheme 2C). Subsequent hydrolysis of the methyl ester intermediate using sodium hydroxide the afforded 11 C-13 in 16% RCY and a specific activity of 205 GBq/µmol. Notably, our method gave a similar yield with a 5-fold improvement in specific activity compared to the oxidative alkoxylation procedure reported by Suzuki and co-workers (44 GBq/µmol and RCY 26±13%). 47 Importantly, the corresponding 11 C-N-cyanobenzamide analogue was synthesized using the optimized conditions for aryl iodides yielding 11 C-12 in 55±8% RCY and a specific activity of 291 GBq/µmol after semi-preparative-HPLC. The radiochemical purity in both syntheses was in excess of 99%. Thus, both the 11 C-labelled parent molecule and its corresponding 11 Ccyanobenzamide bioisostere were efficiently prepared from a common precursor, using similar reaction conditions, further highlighting the utility of the method developed herein.
Conclusions
In conclusion, a palladium mediated 11 C-carbonylative methodology yielding 11 C-N-cyanobenzamides from aryl halides has been described. The substrate scope was found to be excellent and electron rich as well as electron deficient aryl iodides and bromides all performed well. The method was also extended to include the carbonylation of challenging heteroaryl bromides, phenyl triflate and even chlorobenzene. Notably, good to high isolated radiochemical yields were obtained ranging from 28-79% after semi-preparative HPLC. Moreover, the developed method was exemplified by synthesizing novel 11 C-N-cyanobenzamide analogs of the NSAID l as dazoxiben and tamibarotene in 34-71% decay corrected RCY. This method allows rapid and robust access to new 11 Cchemical space and exploration of cyanobenzamide bioisosteres of the ubiquitous carboxylic acid group.
F254 (0.2 mm, Merck) and visualized by UV-light (254 nm).
Flash column chromatography (FCC) was performed using silica gel 60 (40 63 µm, Merck). Analytical UHPLC-MS was performed with an ion-trap mass spectrometer and UV-DAD detection using a C18 (50×3 mm) column using a gradient of 10-90 (1.5 mL/min, 2 min) and MeCN (0.05% HCOOH) in H2O (0.05% HCOOH) as the eluent.
11 CO2 was created through the 14 N(p,n) 11 C nuclear reaction at the Uppsala University Hospital by a Scandtronix MX17 cyclotron and transferred to the hotlab where it was reduced over a bead of zinc (400 °C) and then used in the carbonylation reaction which was remotely controlled. 48 Semi-preparative radio-HPLC was performed using a VWR LaPrep HPLC system (P110, P311) with a Beckman Coutler TM Ultrapshere TM ODS column (10×250mm) with a gradient of 10-90 % (6 mL/min, 10 min) of MeCN in H2O. Analytical radio-HPLC was performed using a VWR LaChrom ELITE system (L-2130, L-2200, L-2400) with a Merck Chromolith Performance RP-18e column (4.6×100mm) and a gradient of 10-90 (method 1: 4 mL/min, 10 min. Method 2: 4 mL/min, 5 min. Method 3: 4 mL/min, 7 min) MeCN in H2O. Both HPLC-systems were buffered with 0.09% TFA (for purification of 11 C-6, 0.1% HCOOH was used), used 254 nm UV-detection and were equipped with a Bioscan FlowCount PMT radioactivity detector. See supporting information for further information.
Synthesis and characterization of precursors and references
Compounds 2a-e, 4a and 4e are known and were synthesized according to reference 24. Compounds 2f, 2g, 4b, 4d, 6, 7 The aryl halide (20 µmol) and cyanamide (16.8 mg, 400 µmol) were added to an oven dried 2 mL vial, capped and flushed for 2 min with argon. To a second oven dried 2 mL vial was added bis(dibenzylideneacetone)-palladium(0) (2.3 mg, 8 µmol) and -bis(diphenyl-phosphino)ferrocene (4.8 mg, 10 µmol) which was then capped and flushed with argon for 2 min before dry DMF (400 µL) was added. After a second flush with argon (2 min) the DMF/Pd(dba)2/dppf solution was heated at 90 °C for 1 min, creating a homogenous solution. The mixture was added to the first vial and subsequently added to the injection loop (200 µL capacity) of the 11 C-carbon monoxide system. 47 After the reaction was finished, the radioactivity was measured. After flushing with nitrogen for 1 min, the activity was measured again yielding the RTE. An aliquot was taken for the determination of RCP. The crude mixture was diluted with 50% aqueous MeCN (total volume 500 µL) and purified by semi-preparative radio-HPLC. After collecting the product, RCP was determined for the pure product. The identity was determined by co-elution of the corresponding nonisotopically labeled N-cyanobenzamide. For the molar activity of 11 C-12 and 11 C-13, a calibration curve with five points using the corresponding reference. The total mass and the concentration of the purified product was then determined. The amount of activity was calculated back to the end of synthesis to get comparable data, expressed in GBq/µmol. The molar activity was determined to be 291 GBq/µmol for 11 C-12 and 205 GBq/µmol for 11 C-13.
